4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-053554
VP, Clinical Trial Operations sold 5,200 shares at $19.11 ($99,351)
- VP, Clinical Trial Operations acquired 5,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-24 | Exercise or conversion : show line 1 in the form | +5,200 | $6.00 | $31,200 | 111,335 | D |
| 2023-10-24 | Sale : show line 2 in the form | −5,200 | $19.11 | $99,351 | 106,135 | D |
| Open-market sales · 5,200 sh · avg $19.11 · $99,351 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-10-24 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −5,200 | $6.00 | 2029-09-20 | 5,200 | 207,653 | D |
Loading xslF345X05/doc4.xml…